Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 13 (CICP13) is a pseudogene, meaning it is a genomic DNA sequence similar to the functional CIC gene but presumed nonfunctional due to accumulated mutations or lack of necessary regulatory signals. Pseudogenes sometimes produce RNA transcripts that can participate in gene regulation by acting as competitive endogenous RNAs (ceRNAs) or miRNA decoys, modulating the expression of their functional parent gene. There is no evidence that CICP13 itself encodes a functional protein or acts as a legitimate therapeutic target. Multiple capicua pseudogenes exist in the human genome, and their functional relevance is largely unknown, with limited evidence for specific roles in disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 13 (CICP13).